Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02488759
Title A Study to Investigate the Safety and Efficacy of Nivolumab in Virus-associated Tumors (CheckMate358)
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Bristol-Myers Squibb
Indications

gastroesophageal junction adenocarcinoma

vaginal cancer

cervical cancer

Merkel cell carcinoma

stomach carcinoma

nasopharynx carcinoma

vulva carcinoma

head and neck cancer

Therapies

Nivolumab

Age Groups: adult
Covered Countries USA


No variant requirements are available.